Mydayis generic availability?

Can I Buy Mydayis Generics?

Mydayis is an extended-release amphetamine medication used to treat attention deficit hyperactivity disorder (ADHD) and binge eating disorder. Lisdexamfetamine, the generic name for Mydayis, has been available since 2014, but the exact timeline for Mydayis generics to enter the market depends on patent expiration.

As of [1] (https://www.drugpatentwatch.com/drug/mydayis#patentexpiration), the first patent for Mydayis (US 9,514,908 B2) expires on April 2029, followed by additional patents that will expire by 2035.

Can I Buy Mydayis Generics Before Patent Expiration?

Although Lisdexamfetamine generics have been available, Mydayis-specific generics might not be immediately available due to remaining patent protection. Pharmaceutical companies often produce generic versions after patents expire to capitalize on lower production costs and potentially higher demand.

Why Are Companies Challenging Mydayis Patents?

Competitors in the ADHD medication market, such as Shire/Otsuka, which developed Mydayis, have been working to extend patent protection and limit competition from generic versions. Companies may contest patent validity or seek new patents to extend market exclusivity.

What Options Do Patients Have?

For patients who require Mydayis, their healthcare providers can prescribe the medication and discuss potential alternatives, including existing generic Lisdexamfetamine or other treatments under a different class of medications.

When Will I Be Able to Buy Mydayis Generics?

The timeline for Mydayis generics' entry to the market is uncertain due to ongoing patent disputes. When the patents expire, manufacturers can begin producing and marketing generic versions of the medication.

Source
[1] DrugPatentWatch.com – Mydayis Patent Expiration Dates.